Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma

Clinical trial NCT05025813 · RECRUITING

Trial details

NCT number: NCT05025813
Sponsor: Queensland Health
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma of the Head and Neck Head and Neck Cancer

Start date: 2022-06-28
Primary completion: 2025-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.